닥플 플러스
KSC 2026 (대한심장학회 제70차 추계학술대회) (1일차)
대한심장학회
연수평점 :6점
오프라인
주관
대한심장학회
교육일자
2026-10-15
수강료
150,000원
교육형태
오프라인
등록일시
2026-09-16
교육시간
60시간 50분
연수평점
6점
장소
서울특별시 그랜드 워커힐 Vista 1 외 8개룸
교육종류
내과, 외과, 소아청소년과, 흉부외과, 영상의학과, 예방의학
타임테이블
| 날짜 | 시간 | 강의명 | 강사 | 구분 |
|---|---|---|---|---|
| 2026-10-15 | 08:30~08:45 | Redefining the Role of DCB in De Novo Lesions | 강동오(고려의대) | - |
| 2026-10-15 | 08:45~09:00 | Who Is the Ideal Candidate for Stentless PCI? | 허애영(강원의대) | - |
| 2026-10-15 | 09:00~09:15 | Can DCB Simplify Bifurcation PCI? | 최기홍(성균관의대) | - |
| 2026-10-15 | 09:15~09:30 | Paclitaxel vs. Sirolimus-Based DCB: Choosing the Right Platform | 김우현(한양의대) | - |
| 2026-10-15 | 09:30~09:45 | Discussion | - | - |
| 2026-10-15 | 09:45~09:55 | Break | - | - |
| 2026-10-15 | 09:55~10:10 | Complete Revascularization in Myocardial Infarction: Immediate or Staged? | 김민철(전남의대) | - |
| 2026-10-15 | 10:10~10:25 | Angio-Derived FFR-Guided Revascularization: The Era of Wire-Free Physiology | 조성우(인제의대) | - |
| 2026-10-15 | 10:25~10:40 | CTO PCI Reconsidered: Symptoms vs. Prognosis After ORBITA-CTO | 신상훈(이화의대) | - |
| 2026-10-15 | 10:40~10:55 | Coronary Revascularization Before TAVR: Is It Worth the Risk? | 국형돈(한양의대) | - |
| 2026-10-15 | 10:55~11:10 | Discussion | - | - |
| 2026-10-15 | 11:10~11:20 | Break | - | - |
| 2026-10-15 | 11:20~11:35 | 논문쓰는 사람의 현실: 논문작성이 이렇게 힘든 작업인가? | 곽순구(서울의대) | - |
| 2026-10-15 | 11:35~11:50 | 배우는 사람에서 가르치는 사람으로(교육): 후배를 가르치면서 내가 배운 것들 | 김태오(울산의대) | - |
| 2026-10-15 | 11:50~12:05 | 버티는 법, 회복하는 법(번아웃): 지치지 않고 오래 일하기 | 차지현(성균관의대) | - |
| 2026-10-15 | 12:05~12:20 | 병원 안의 인간관계: 좋은 동료가 좋은 의사를 만든다 | 이승준(연세의대) | - |
| 2026-10-15 | 12:20~12:35 | Discussion | - | - |
| 2026-10-15 | 12:35~13:45 | Lunch & Break | - | - |
| 2026-10-15 | 13:45~14:00 | 심장내과 의사가 진료 중 궁금했던 심장병리를 병리의사에게 묻는다 | 김은경(성균관의대) | - |
| 2026-10-15 | 14:00~14:15 | Learning through the ischemic heart disease | 김정선(성균관의대) | - |
| 2026-10-15 | 14:15~14:30 | Learning through the valvular heart disease | 고지원(서울의대) | - |
| 2026-10-15 | 14:30~14:45 | Learning through the cardiomyopathy | 김은나(서울의대) | - |
| 2026-10-15 | 14:45~15:00 | Discussion | - | - |
| 2026-10-15 | 15:00~15:10 | Break | - | - |
| 2026-10-15 | 15:10~15:25 | Key Updates in the ESC 2026 Heart Failure Guidelines: What Changed and Why? | Lars Køber(Rigshospitalet - Copenhagen University Hospital, Denmark) | - |
| 2026-10-15 | 15:25~15:40 | From Guidelines to Bedside: Practical Implementation of Contemporary HF Care | Darae Kim(Sungkyunkwan Univ., Korea) | - |
| 2026-10-15 | 15:40~15:55 | The Expanding Role of Comorbidity Management in Modern HF Guidelines | Lars Køber(Rigshospitalet - Copenhagen University Hospital, Denmark) | - |
| 2026-10-15 | 15:55~16:10 | Multidisciplinary and Patient-Centered Approaches in HF Care | Minjae Yoon(Seoul Univ., Korea) | - |
| 2026-10-15 | 16:10~16:25 | Discussion | - | - |
| 2026-10-15 | 16:25~16:35 | Break | - | - |
| 2026-10-15 | 16:35~16:50 | TAVI in Asymptomatic Severe Aortic Stenosis | David J. Cohen(St. Francis Hospital, USA) | - |
| 2026-10-15 | 16:50~17:05 | Incidence and Predictors of Reintervention After TAVR | Jung-Min Ahn(Ulsan Univ., Korea) | - |
| 2026-10-15 | 17:05~17:20 | Surgery Remains the Only Class I Indication | Hyung Gon Je(Seoul National Univ., Korea) | - |
| 2026-10-15 | 17:20~17:35 | Why Not TAVR? | Byung-Hee Hwang(Catholic Univ., Korea) | - |
| 2026-10-15 | 17:35~17:50 | Discussion | - | - |
| 2026-10-15 | 08:30~08:45 | Mitral TEER: From Patient Selection to Clip Optimization | Makoto Amaki(National Cerebral and Cardiovascular Center, Japan) | - |
| 2026-10-15 | 08:45~09:00 | Multi-modality Imaging for TAVR: Echo, CT, and Intraprocedural Guidance | Jae Yeong Cho(Chonnam National Univ., Korea) | - |
| 2026-10-15 | 09:00~09:15 | Imaging for Transcatheter Tricuspid Interventions | Eun Kyoung Kim(Sungkyunkwan Univ., Korea) | - |
| 2026-10-15 | 09:15~09:30 | Echo Guidance for Alcohol Septal Ablation in HOCM | Dong-Hyuk Cho(Korea Univ., Korea) | - |
| 2026-10-15 | 09:30~09:45 | Discussion | - | - |
| 2026-10-15 | 09:45~09:55 | Break | - | - |
| 2026-10-15 | 09:55~10:10 | The Role of Myocardial Strain in Asymptomatic Severe VHD: When to Intervene | Marielle Scherrer-Crosbie(Hospital of the University of Pennsylvania, USA) | - |
| 2026-10-15 | 10:10~10:25 | Clinical Dilemmas and Decision-making in Symptomatic Moderate and Mixed Aortic Valve Disease | Sung Ji Park(Sungkyunkwan Univ., Korea) | - |
| 2026-10-15 | 10:25~10:40 | Mitral Regurgitation Phenotyping: Degenerative, Ventricular, and Atrial Functional MR and Implications for Intervention | Makoto Amaki(National Cerebral and Cardiovascular Center, Japan) | - |
| 2026-10-15 | 10:40~10:55 | Advanced Risk Stratification and Data-Driven Phenotyping in Mitral Regurgitation | Soongu Kwak(Seoul National Univ., Korea) | - |
| 2026-10-15 | 10:55~11:10 | Discussion | - | - |
| 2026-10-15 | 11:10~11:20 | Break | - | - |
| 2026-10-15 | 11:20~11:35 | Winrevair (Sotartercept), Activin Signaling Inhibitor for Group 1 Pulmonary Hypertesion & Group 2 Pulmonary Hypertesion | 김대희(울산의대) | - |
| 2026-10-15 | 11:35~11:50 | Opsynvi (Macitentan+Tadarafil) for Group 1 Pulmonary Hypertesion | 최정현(부산의대) | - |
| 2026-10-15 | 11:50~12:05 | Riociguat, sGC Stimulator, for Group 1 Pulmonary Hypertesion & Group 4 Pulmonary Hypertesion | 장성아(성균관의대) | - |
| 2026-10-15 | 12:05~12:20 | Balloon Pulmonary Angioplasty for Group 4 Pulmonary Hypertesion | 안철민(연세의대) | - |
| 2026-10-15 | 12:20~12:35 | Discussion | - | - |
| 2026-10-15 | 12:35~13:45 | Lunch & Break | - | - |
| 2026-10-15 | 13:45~14:00 | Atypical ACS Symptoms and Sex-related Diagnostic Delays | 김송이(제주의대) | - |
| 2026-10-15 | 14:00~14:15 | Troponin Sex-specific Cutoffs and Implications | 허애영(강원의대) | - |
| 2026-10-15 | 14:15~14:30 | HFpEF: Why Women Are Disproportionately Affected | 전경현(연세의대) | - |
| 2026-10-15 | 14:30~14:45 | CMR and CCTA: Optimization of Imaging for Women | 이상은(연세의대) | - |
| 2026-10-15 | 14:45~15:00 | Discussion | (이화의대) | - |
| 2026-10-15 | 15:00~15:10 | Break | - | - |
| 2026-10-15 | 15:10~15:25 | Undertreatment of Women with ACS: Evidence, Causes, and Solutions | 안준호(전남의대) | - |
| 2026-10-15 | 15:25~15:40 | PCI Outcomes in Women: Radial Access, Smaller Vessel Anatomy, Stent Sizing | 원호연(중앙의대) | - |
| 2026-10-15 | 15:40~15:55 | Antiplatelet & Anticoagulant Therapy: Sex Differences in Bleeding vs. Ischemic Risk | 서정원(서울의대) | - |
| 2026-10-15 | 15:55~16:10 | Cardiac Rehabilitation: Low Participation Rates in Women and Tailored Strategies | 배성아(연세의대) | - |
| 2026-10-15 | 16:10~16:25 | Discussion | - | - |
| 2026-10-15 | 16:25~16:35 | Break | - | - |
| 2026-10-15 | 16:35~16:50 | LDL Cholestetrol Targeting in Atherosclerotic Cardiovascular Disease: The Ez-PAVE Trial & More | Byeong-Keuk Kim(Yonsei Univ., Korea) | - |
| 2026-10-15 | 16:50~17:05 | Transcatheter Tricuspid Valve Therapy: Initial US Commercial Experience | Wayne Batchelor(Inova Health System, USA) | - |
| 2026-10-15 | 17:05~17:20 | Beta Blocker Therapy After Myocardial Infarction: The SMART-DECISION Trial & More | Joo-Yong Hahn(Sungkyunkwan Univ., Korea) | - |
| 2026-10-15 | 17:20~17:35 | Contemporary Landscape of Treatment of Aortic Regurgitation | Aakriti Gupta(Cedars-Sinai Medical Center, USA) | - |
| 2026-10-15 | 17:35~17:50 | Discussion | - | - |
| 2026-10-15 | 08:30~08:45 | Evolution of Shock Team-Based Care | 이상협(연세의대) | - |
| 2026-10-15 | 08:45~09:00 | Echocardiography in Cardiogenic Shock: Beyond LVEF | 김미주(충남의대) | - |
| 2026-10-15 | 09:00~09:15 | Contemprary Hemodynamic Monitoring in Cardiogenic Shock | 김아람(울산의대) | - |
| 2026-10-15 | 09:15~09:30 | Beyond Norepinephrine: Practical Use of Inotropes and Vasopressors | 이수용(부산의대) | - |
| 2026-10-15 | 09:30~09:45 | Heart-Lung Interactions in Cardiogenic Shock | 김인철(계명의대) | - |
| 2026-10-15 | 09:45~09:55 | Break | - | - |
| 2026-10-15 | 09:55~10:10 | Selecting Candidates for Central ECMO | 김지훈(한림의대) | - |
| 2026-10-15 | 10:10~10:25 | Mechanical Ventilation Strategies in MCS Patients | 고령은(성균관의대) | - |
| 2026-10-15 | 10:25~10:40 | Renal Replacement Therapy During ECMO | 차지현(성균관의대) | - |
| 2026-10-15 | 10:40~10:55 | Antithrombotic Management in ECMO Patients | 강지훈(서울의대) | - |
| 2026-10-15 | 10:55~11:10 | Which Patients Benefit Most from Impella? | 김민철(전남의대) | - |
| 2026-10-15 | 11:10~11:20 | Break | - | - |
| 2026-10-15 | 11:20~11:35 | 5th Universal Definition of MI: 무엇이 바뀌고, 왜 중요한가? | 강민규(경상의대) | - |
| 2026-10-15 | 11:35~11:50 | 응급실 실전 활용: 최신 ACC/AHA & ESC ACS 가이드라인 핵심을 알려주마 | 우종신(경희의대) | - |
| 2026-10-15 | 11:50~12:05 | 2026 심근경색연구회 재관류 진료지침 무엇이 어떻게 바뀌었나? | 황도연(서울의대) | - |
| 2026-10-15 | 12:05~12:20 | AI-ECG 기반 심근경색증 진단 및 이송 전략의 현재와 미래 | 류현욱(경북의대) | - |
| 2026-10-15 | 12:20~12:35 | Discussion | - | - |
| 2026-10-15 | 12:35~13:45 | Lunch & Break | - | - |
| 2026-10-15 | 13:45~14:00 | 조영술만으로는 부족하다? IVUS/OCT는 심근경색중재시술에 필수적인가? | 차정준(고려의대) | - |
| 2026-10-15 | 14:00~14:15 | Cath Lab으로 들어온 인공지능: 심근경색 다혈관질환에서 AI기반 FFR은 필요한가? | 이주명(성균관의대) | - |
| 2026-10-15 | 14:15~14:30 | 약물코팅풍선 전성시대: 심근경색 중재시술에도 유용한가? | 강동오(고려의대) | - |
| 2026-10-15 | 14:30~14:45 | 심인성 쇼크 치료의 대전환: 임펠라와 에크모 어떻게 적용할까? | 임용환(전남의대) | - |
| 2026-10-15 | 14:45~15:00 | Discussion | - | - |
| 2026-10-15 | 15:00~15:10 | Break | - | - |
| 2026-10-15 | 15:10~15:25 | Metabolic Origins of Inflammation | 박훈준(가톨릭의대) | - |
| 2026-10-15 | 15:25~15:40 | Vascular and Systemic Inflammation | 주형준(고려의대) | - |
| 2026-10-15 | 15:40~15:55 | Lp(a) as a Novel Therapeutic Target in Cardiovascular Therapy | 위진(가천의대) | - |
| 2026-10-15 | 15:55~16:10 | Inflammatory Biomarkers and Cardiovascular Risk Stratification | 이상언(울산의대) | - |
| 2026-10-15 | 16:10~16:25 | Discussion | - | - |
| 2026-10-15 | 16:25~16:35 | Break | - | - |
| 2026-10-15 | 16:35~16:50 | Clinical Obesity: Evolution and Definition | 김보연(순천향의대) | - |
| 2026-10-15 | 16:50~17:05 | Fat and the Heart: The Cardiovascular Impact of Obesity | 김경희(인천세종병원) | - |
| 2026-10-15 | 17:05~17:20 | Social Determinants of Health in Obesity Management | 박승준(경희의대) | - |
| 2026-10-15 | 17:20~17:35 | Multidimensional Approaches in Contemporary Obesity Therapy | 서미혜(순천향의대) | - |
| 2026-10-15 | 17:35~17:50 | Discussion | - | - |
| 2026-10-15 | 08:30~08:45 | Pressure Tracing Never Lies | 박찬순(울산의대) | - |
| 2026-10-15 | 08:45~09:00 | When Less is More in Cardiovascular Care | 이용구(한양의대) | - |
| 2026-10-15 | 09:00~09:15 | The Most Expensive Test Isn't the One You Need | 김미정(가톨릭의대) | - |
| 2026-10-15 | 09:15~09:30 | Can AI Understand Physiology? | 박준범(이화의대) | - |
| 2026-10-15 | 09:30~09:45 | Discussion | - | - |
| 2026-10-15 | 09:45~09:55 | Break | - | - |
| 2026-10-15 | 09:55~10:10 | Catheter Ablation of AF in HFpEF: From "Why Not?" to "Why Wait?" | Kina Jeon(Catholic Univ., Korea) | - |
| 2026-10-15 | 10:10~10:25 | Beyond the Catheter: Why Lifestyle Modification Is the Cornerstone of AF Ablation Success | Jum Seok Ko(Wonkwang Univ., Korea) | - |
| 2026-10-15 | 10:25~10:40 | Targeting the Autonomic Nervous System in Atrial Fibrillation: From Pathophysiology to Clinical Intervention | André Ng(University of Leicester, UK) | - |
| 2026-10-15 | 10:40~10:55 | Beyond the Diagnosis: Why AF Burden Is the New Gold Standard for Risk Stratification | Ki Hong Lee(Chonnam National Univ., Korea) | - |
| 2026-10-15 | 10:55~11:10 | Discussion | - | - |
| 2026-10-15 | 11:10~11:20 | Break | - | - |
| 2026-10-15 | 11:20~11:35 | Interventional Cardiology: Rewriting Antiplatelet Therapy and Beyond | 강지훈(서울의대) | - |
| 2026-10-15 | 11:35~11:50 | Heart Failure: A New Definition of HF Types, CKM Syndrome, and the HFpEF Revolution | 이선기(고려의대) | - |
| 2026-10-15 | 11:50~12:05 | Electrophysiology: From VASc to VA, and RV to Conduction System | 박승정(성균관의대) | - |
| 2026-10-15 | 12:05~12:20 | Cardiovascular Disease in Pregnancy: A Paradigm Shift | 박성미(고려의대) | - |
| 2026-10-15 | 12:20~12:35 | Valvular Heart Disease: Redrawing the Lines Between Surgery and Intervention | 최홍미(서울의대) | - |
| 2026-10-15 | 12:35~13:45 | Lunch & Break | - | - |
| 2026-10-15 | 13:45~14:00 | Early Intervention in Persistent AF: Incorporating Lessons from AVANT GUARD into Substrate-Based Strategies | 오일영(서울의대) | - |
| 2026-10-15 | 14:00~14:15 | Transforming the Strategy for Persistent AF: High-Efficiency Substrate Modification in the Era of PFA | 김준(울산의대) | - |
| 2026-10-15 | 14:15~14:30 | The Great PFA Debate: To Map or Not to Map in Persistent AF? Pros: "3D Mapping Is Essential for Persistent AF" | 박형섭(계명의대) | - |
| 2026-10-15 | 14:30~14:45 | The Great PFA Debate: To Map or Not to Map in Persistent AF? Cons: "Fluoro-only PFA Is the Future of Efficiency" | 김대훈(연세의대) | - |
| 2026-10-15 | 14:45~15:00 | Discussion | - | - |
| 2026-10-15 | 15:00~15:10 | Break | - | - |
| 2026-10-15 | 15:10~15:25 | Less Is More? Contemporary Antithrombotic Strategies for AF and CAD | 이승준(연세의대) | - |
| 2026-10-15 | 15:25~15:40 | Left Atrial Appendage Occlusion in 2026: Who Truly Benefits? | 신승용(고려의대) | - |
| 2026-10-15 | 15:40~15:55 | Factor XIa Inhibitors and the Future of Precision Antithrombotic Therapy | 박예민(가천의대) | - |
| 2026-10-15 | 15:55~16:10 | Artificial Intelligence-Based Biological Risk Profiling in AF | 백용수(인하의대) | - |
| 2026-10-15 | 16:10~16:25 | Discussion | - | - |
| 2026-10-15 | 16:25~16:35 | Break | - | - |
| 2026-10-15 | 16:35~16:50 | The Necessity for the Birth of CKLM Syndrome: From the Cradle to the Grave | 임수(서울의대) | - |
| 2026-10-15 | 16:50~17:05 | MASLD, the New Kid on the Block: Why the Liver Joins the Equation | 전대원(한양의대) | - |
| 2026-10-15 | 17:05~17:20 | One Drug, Multiple Organs: GLP-1 RA and the Cardiometabolic Continuum | Plutzky(Havard University) | - |
| 2026-10-15 | 17:20~17:35 | I am a Doctor Taking Weight-Loss Injections (나는 비만 주사를 맞는 의사다) | 장형우(서울의대) | - |
| 2026-10-15 | 17:35~17:50 | Discussion | - | - |
| 2026-10-15 | 08:30~08:45 | LDL-Lowering Therapy in High-Risk Patients: Where Do Guidelines Stand in 2026? | Ji Hyun Kim(Catholic Univ., Korea) | - |
| 2026-10-15 | 08:45~09:00 | From FOURIER to VESALIUS-CV: Expanding the Scope of PCSK9 Inhibitor Therapy | Doyeon Hwang(Seoul National Univ., Korea) | - |
| 2026-10-15 | 09:00~09:15 | Cardiovascular Outcomes in Patients at High CV Risk: Evidence From the VESALIUS-CV Study | Jan Hein Cornel(Northwest Clinics, Netherlands) | - |
| 2026-10-15 | 09:15~09:30 | Implementing PCSK9 Inhibitors in Real-World Clinical Practice: Korean Perspective | Oh Hyun Lee(Yonsei Univ., Korea) | - |
| 2026-10-15 | 09:30~09:45 | Discussion | - | - |
| 2026-10-15 | 09:45~09:55 | Break | - | - |
| 2026-10-15 | 09:55~10:10 | Artificial Intelligence in Cardiovascular Disease Prevention: Is It Ready for Prime Time? | Fatima Rodriguez(Stanford Univ., USA) | - |
| 2026-10-15 | 10:10~10:25 | AI for Precision Cardiovascular Risk Prediction: Beyond Traditional Risk Scores | Hanjin Park(Yonsei Univ., Korea) | - |
| 2026-10-15 | 10:25~10:40 | AI-Driven Strategies for Primary Prevention of Cardiovascular Disease | Sang Youl Rhee(Kyung Hee Univ., Korea) | - |
| 2026-10-15 | 10:40~10:55 | AI-Enabled Secondary Prevention: Predicting Heart Failure Outcomes and Rehospitalization | Kyung-Hee Kim(Sejong Hospital, Korea) | - |
| 2026-10-15 | 10:55~11:10 | Discussion | - | - |
| 2026-10-15 | 11:10~11:20 | Break | - | - |
| 2026-10-15 | 11:20~11:35 | The Cardiovascular-Kidney-Metabolic (CKM) Syndrome Framework: Implications for CVD Prevention | Hokyou Lee(Yonsei Univ., Korea) | - |
| 2026-10-15 | 11:35~11:50 | Endocrine Perspective on CKM Syndrome: Implications for CVD Prevention | Soo Lim(Seoul National Univ., Korea) | - |
| 2026-10-15 | 11:50~12:05 | Kidney Perspective on CKM Syndrome: Implications for CVD Prevention | Hyo Jeong Kim(National Health Insurance Service Ilsan Hospital, Korea) | - |
| 2026-10-15 | 12:05~12:20 | Liver Perspective on CKM Syndrome: Implications for CVD Prevention | Hye-Won Lee(Yonsei Univ., Korea) | - |
| 2026-10-15 | 12:20~12:35 | Discussion | - | - |
| 2026-10-15 | 12:35~13:45 | Lunch & Break | - | - |
| 2026-10-15 | 13:45~14:00 | Redefining Heart Failure Phenotypes: Beyond EF and Congestion | Gurusher Panjrath(George Washington University School of Medicine and Health Sicences, USA) | - |
| 2026-10-15 | 14:00~14:15 | Imaging-Guided Precision Phenotyping in Heart Failure | Sung-Hee Shin(Inha Univ., Korea) | - |
| 2026-10-15 | 14:15~14:30 | Advanced Heart Failure in 2026: Timing, Technology, and Tough Decisions | Amanda R. Vest(Cleveland Clinic, USA) | - |
| 2026-10-15 | 14:30~14:45 | Novel HF Therapies in Clinical Practice: Opportunities and Challenges | In-Cheol Kim(Keimyung Univ., Korea) | - |
| 2026-10-15 | 14:45~15:00 | Discussion | - | - |
| 2026-10-15 | 15:00~15:10 | Break | - | - |
| 2026-10-15 | 15:10~15:25 | Evolution of Intracoronary Imaging: From Conventional Imaging to AI-Integrated Imaging | 김용철(연세의대) | - |
| 2026-10-15 | 15:25~15:40 | Inovations in Echocardiography for Early Detection of Ischemic Heart Disease: Including AI Echocardiography | 박지석(서울의대) | - |
| 2026-10-15 | 15:40~15:55 | Artificial Intelligence–Based ECG Analysis in Coronary Artery Disease | 조영진(서울의대) | - |
| 2026-10-15 | 15:55~16:10 | Nuclear Cardioogy in Ischemic Heart Disease: Recent Update | 박기성(전남의대) | - |
| 2026-10-15 | 16:10~16:25 | Photon-Counting CT in Ischemic Heart Disease: Redefining Coronary Imaging | 박은아(서울의대) | - |
| 2026-10-15 | 16:25~16:35 | Break | - | - |
| 2026-10-15 | 16:35~16:50 | Post-Cancer Accelerated CV aging - Inflammation as a Shared Pathway | June-Wha Rhee(City of Hope Comprehensive Medical Center, USA) | - |
| 2026-10-15 | 16:50~17:05 | Body Composition Changes and CKM Risk after Cancer Treatment | Mi-Hyang Jung(Catholic Univ., Korea) | - |
| 2026-10-15 | 17:05~17:20 | Role of Exercise and Rehabilitation in Post-Cancer CV Risks | Kyuwan Lee(Ewha Womans University, Korea) | - |
| 2026-10-15 | 17:20~17:35 | Potential Role of GLP-1 Agonists and Metabolic Interventions for Cancer Survivors | Jee Hee Yoon(Chonnam National Univ., Korea) | - |
| 2026-10-15 | 17:35~17:50 | Discussion | - | - |
| 2026-10-15 | 08:30~08:40 | (Abstract) AI-ECG Guided Risk Stratification for Atrial Fibrillation Detection After Acute Ischemic Stroke: A Real-World Prospective Cohort Operationalizing AI in the Clinical Workflow | Yongsoo Baek(Inha Univ., Korea) | - |
| 2026-10-15 | 08:40~08:50 | (Abstract) Virtual Atrial Fibrillation Dynamics Reflect Clinical Outcomes After Catheter Ablation | Taehyun Hwang(Yonsei Univ., Korea) | - |
| 2026-10-15 | 08:50~09:00 | (Abstract) Rhythm findings from implantable loop recorder registry in embolic stroke of undetermined source: predictors and treatment response of clinically significant atrial fibrillation - A single center, retrospective, observational study | Ohchul Kwon(Seoul Univ., Korea) | - |
| 2026-10-15 | 09:00~09:10 | (Abstract) Feasibility and Safety of Intracardiac Echocardiography?Guided Zero-Fluoroscopy Pulsed-Field Ablation for Atrial Fibrillation | Moonki Jung(Chung-Ang Univ., Korea) | - |
| 2026-10-15 | 09:10~09:20 | (Abstract) A multimodal artificial intelligence approach for atrial fibrillation subtype classification and post-ablation recurrence risk stratification | Oh-Seok Kwon(Yonsei Univ., Korea) | - |
| 2026-10-15 | 09:20~09:30 | (Abstract) Urban - Rural Differences in the Clinical Course and Outcomes of Atrial Fibrillation | Ahtam Tolibov(Republican Specialized Scientific and Practical Medical Center of Cardiology, Uzbekistan) | - |
| 2026-10-15 | 09:30~09:40 | (Abstract) The 1-in-10 Dilemma: Real-World Bleeding Prevalence and Predictors in AHRE Patients on Anticoagulation | Mohammad Akram M Ramli(University Malaya Medical Centre, Malaysia) | - |
| 2026-10-15 | 09:40~09:55 | Break | - | - |
| 2026-10-15 | 09:55~10:05 | (Abstract) High-Intensity Versus Non-High-Intensity Statin Therapy in AMI Patients Achieving LDL-C | Jaeyong Lee(Daegu Catholic Univ., Korea) | - |
| 2026-10-15 | 10:05~10:15 | (Abstract) One-month high sensitivity C-reactive protein versus lipid-related markers for residual risk after percutaneous coronary intervention: a retrospective cohort study | Donghyeon Joo(Wonkwang Univ., Korea) | - |
| 2026-10-15 | 10:15~10:25 | (Abstract) Long term prognostic impact of high intensity statin in elderly diabetic patients with AMI from KAMIR-NIH-LIPID Registry | Kyeong Seok Oh(Chungbuk National Univ., Korea) | - |
| 2026-10-15 | 10:25~10:35 | (Abstract) Sex Differences in Perivascular Adipose Tissue Inflammation in Patients with Suspected Coronary Artery Disease: A Deep Learning-Based Analysis Using Coronary Computed Tomographic Angiography | Wenxi Han(Anhui University of Chinese Medicine, Sichuan University, China) | - |
| 2026-10-15 | 10:35~10:45 | (Abstract) Prognostic Value of Thigh Circumference as new Anthropometric Parameter in Patients With Acute Myocardial Infarction | Youngjoon Kwon(Kyungpook National Univ., Korea) | - |
| 2026-10-15 | 10:45~10:55 | (Abstract) Late Residual Risk in Event-Free Survivors of Acute Myocardial Infarction | Doo Sun Sim(Chonnam National Univ., Korea) | - |
| 2026-10-15 | 10:55~11:05 | (Abstract) Impact of Coronary Artery Spasm on 10-Year Clinical Outcomes in Mild-to-Moderate Atherosclerosis | Seung-Woon Rha(Korea Univ., Korea) | - |
| 2026-10-15 | 11:05~11:20 | Break | - | - |
| 2026-10-15 | 11:20~11:30 | (Abstract) Randomized Comparison of Safety and Efficacy of Pulsed Field Ablation in Atrial Fibrillation Patients Treated with a Penta-spline versus a Fixed-Loop Circular Catheter | 남웅(중앙의대) | - |
| 2026-10-15 | 11:30~11:40 | (Abstract) Right Heart Reverse Remodeling After Catheter Ablation of Atrial Fibrillation: Association With Tricuspid Regurgitation Response in Severe Functional TR | 김동현(울산의대) | - |
| 2026-10-15 | 11:40~11:50 | (Abstract) Left atrial reverse remodeling is prognostic but does not capture statin-related clinical benefit in atrial fibrillation: a multicenter observational study with external validation | 김인수(연세의대) | - |
| 2026-10-15 | 11:50~12:00 | (Abstract) Cardiopulmonary Exercise Capacity as an Effect Modifier of Catheter Ablation Benefit in Persistent Atrial Fibrillation | 김민정(이화의대) | - |
| 2026-10-15 | 12:00~12:10 | (Abstract) The Association between Life’s Essential 8, Alcohol Consumption, and the Incidence of Atrial Fibrillation: An Analysis using UK Biobank Data | 김도영(가톨릭의대) | - |
| 2026-10-15 | 12:10~12:20 | (Abstract) Discontinuation of Anticoagulation in Patients at Relatively High Risk of Stroke After Successful Catheter Ablation for Atrial Fibrillation: A Nationwide Cohort Study | 이영신(경희의대) | - |
| 2026-10-15 | 12:20~12:30 | (Abstract) Prognotic Impact of Body Composition Phenotypes in Atrial Fibrillation: Insights from the UK Biobank | 김홍주(동강병원) | - |
| 2026-10-15 | 12:30~13:45 | Lunch & Break | - | - |
| 2026-10-15 | 13:45~13:53 | (Case) Ventricular septal defect with Eisenmenger... or not? | Yan Limin(National Heart Centre Singapore, Singapore) | - |
| 2026-10-15 | 13:53~14:01 | (Case) Exercise stress echocardiography to predict recovery of left ventricular function after primary percutaneous coronary intervention in acute coronary syndromes | Seweon Kim(Yonsei Univ., Korea) | - |
| 2026-10-15 | 14:01~14:09 | (Case) Multimodal Imaging of Cardiac Complications in Granulomatosis With Polyangiitis: Aortitis, Complete Atrioventricular Block, and Eccentric Aortic Regurgitation | Ha Hye Jo(Hanyang Univ., Korea) | - |
| 2026-10-15 | 14:09~14:17 | (Case) Unmasking a Large Middle Mediastinal Paraganglioma: The Role of Multimodality Cardiovascular Imaging in Diagnosis and Surgical Planning | Shelley Lauren S. Cham(Makati Medical Center, Philippines, Philippines) | - |
| 2026-10-15 | 14:17~14:25 | (Case) Reversible Constrictive Physiology as the Presenting Feature of Tuberculous Pericarditis in a Young Healthcare Worker: A Diagnostic Odyssey | Pramudya Astrid(Faculty of Medicine, Universitas Brawijaya, Indonesia) | - |
| 2026-10-15 | 14:25~14:33 | (Case) Echocardiographic Features in the Diagnosis and Prognosis of a Rare Malignant Left Atrial Leiomyosarcoma Invading the Mitral Annulus Mimicking Benign Myxoma: A Case Report | Tuoi Nguyen Thi Hong(Tam Anh General Hospital of Ho Chi Minh City, Vietnam) | - |
| 2026-10-15 | 14:33~14:41 | (Case) Platypnea-Orthodeoxia Syndrome as a Cause of Recurrent Positional Transient Loss of Consciousness : A Diagnostic Role of Tilt Table Testing in Patient with Patent Foramen Ovale | Diajeng Putri Dewanti(National Cardiovascular Center Harapan Kita, Indonesia) | - |
| 2026-10-15 | 14:41~14:49 | (Case) ALCAPA in elderly patient presented as sudden death. | Sergei Iakovlev(Botkin Hospital, Moscow, Russian Federation, Russian Federation) | - |
| 2026-10-15 | 14:49~14:57 | (Case) Role of Multimodality Imaging in the Diagnosis of Post-TAVR Infective Endocarditis | Jung Jiyoon(Yonsei Univ., Korea) | - |
| 2026-10-15 | 14:57~15:10 | Break | - | - |
| 2026-10-15 | 15:10~15:20 | (Abstract) Clonal Hematopoiesis Predicts Postoperative Complications and Distinct Perioperative Immune Remodeling After Surgical Aortic Valve Replacement | Yoonjin Kang(Seoul Univ., Korea) | - |
| 2026-10-15 | 15:20~15:30 | (Abstract) Intravital Multispectral Imaging Reveals that Psychological Stress Accelerates Myeloid Cell Recruitment and Pro-Inflammatory Macrophage Polarization in Atherosclerotic Plaques | Seung Ho Shin(Korea Univ., Korea) | - |
| 2026-10-15 | 15:30~15:40 | (Abstract) Development of a Scalable and Reproducible Human Cardiac Organoid Model Enabled by Optimized Sequential Differentiation | Sooji Yoo(Chonnam National Univ., Korea) | - |
| 2026-10-15 | 15:40~15:50 | (Abstract) Long-Term Multiorgan Outcomes After Neonatal Congenital Heart Surgery: Biventricular Repair versus Staged Intervention in a Nationwide IPTW-Adjusted Competing-Risk Cohort | Jihye You(Jeonbuk National Univ., Korea) | - |
| 2026-10-15 | 15:50~16:00 | (Abstract) Identification of Atrial Arrhythmia Using Artificial Intelligence Analysis of Sinus Rhythm Holter ECG in Adults With Repaired Tetralogy of Fallot | Seung Min Baek(Seoul Univ., Korea) | - |
| 2026-10-15 | 16:00~16:10 | (Abstract) A primate genetic model organism for cardiovascular disease | Stephen Chang(Stanford University School of Medicine, Stanford University School of Medicine, United States) | - |
| 2026-10-15 | 16:10~16:35 | Break | - | - |
| 2026-10-15 | 16:35~16:45 | (Abstract) Statin therapy and total mortality in individuals with different lipoprotein(a) levels | Yujin Shin(Yonsei Univ., Korea) | - |
| 2026-10-15 | 16:45~16:55 | (Abstract) Exercise Hemodynamic Characterization of Obese Heart Failure With Preserved Ejection Fraction | David Hong(Sungkyunkwan Univ., Korea) | - |
| 2026-10-15 | 16:55~17:05 | (Abstract) Artificial intelligence-enabled electrocardiography to predict left ventricular ejection fraction decline in patients with symptomatic obstructive hypertrophic cardiomyopathy receiving mavacamten | Jee-Woong Choi(Seoul Univ., Korea) | - |
| 2026-10-15 | 17:05~17:15 | (Abstract) Clinical Characteristics and Outcomes of Patients with Right Ventricular-Dominant Cardiogenic Shock on Venoarterial Extracorporeal Membrane Oxygenation | Ye Chan Kim(Sungkyunkwan Univ., Korea) | - |
| 2026-10-15 | 17:15~17:25 | (Abstract) Clinical Risk and Long-Term Outcomes After Fractional Flow Reserve- versus Intravascular Ultrasound-Guided Percutaneous Coronary Intervention | Jihun Song(Keimyung Univ., Korea) | - |
| 2026-10-15 | 17:25~17:35 | (Abstract) Clonal hematopoiesis of indeterminate potential and progression from paroxysmal to persistent atrial fibrillation | Jae-Hyun Kim(Seoul Univ., Korea) | - |
| 2026-10-15 | 08:30~08:40 | (Abstract) Differential Association of Appendicular Skeletal Muscle Mass with Hypertension by Measurement Modality (DXA vs. BIA) and the Role of Adiposity : The Korea National Health and Nutrition Examination Survey 2024 | JuneYoung Yoon(Wonkwang Univ., Korea) | - |
| 2026-10-15 | 08:40~08:50 | (Abstract) CT-Based Quantitative Analysis of Cardiothoracic Structural and Pulmonary Functional Changes in Male Patients with Silicosis and Comorbid Hypertension | Yue Lin(West China Fourth Hospital, Sichuan University, China) | - |
| 2026-10-15 | 08:50~09:00 | (Abstract) Hemodynamic Changes in a Subnephrectomized Rat Model of Concurrent Hypertension and Type 2 Diabetes Mellitus: A Pre-Clinical Experimental Study | Reza Wahyuningsih(Universitas Islam Indonesia, Indonesia) | - |
| 2026-10-15 | 09:00~09:10 | (Abstract) Awareness and Practices of Physicians Regarding Updated European Society of Cardiology and European Society of Hypertension Guidelines | Aiisha Tileuzhan(Universitas Islam Indonesia, Indonesia) | - |
| 2026-10-15 | 09:10~09:20 | (Abstract) The Nitric Oxide Synthase 3 G894T Polymorphism is Associated with Hypertension in the Rural Melanesian Population: an Insight from Eastern Indonesia | Widyan Putra Anantawikrama(National Cardiovascular Center Harapan Kita/ Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia) | - |
| 2026-10-15 | 09:20~09:55 | Break | - | - |
| 2026-10-15 | 09:55~10:05 | (Abstract) Comparative Performance of Inflammatory and Nutritional Biomarkers in Discriminating Chronic Limb-Threatening Ischemia Among Patients with Peripheral Artery Disease | Abiseka Panji Baskoro(Universitas Sebelas Maret Hospital, Indonesia) | - |
| 2026-10-15 | 10:05~10:15 | (Abstract) Novel Device of screening CAD by Non-invasive Estimation of Coronary Resistance and Compliance: Prospective Diagnostic and Retrospective Validation Study. | Byoung Kwon Lee(Yonsei Univ., Korea) | - |
| 2026-10-15 | 10:15~10:25 | (Abstract) Soluble P-Selectin’s Strength as an Adjunctive Biomarker for Deep Vein Thrombosis in Cancer Patients: An Analytic Cross-Sectional Study | Eka Fithra Elfi(Dr. M. Djamil General Hospital Padang, Faculty of Medicine Universitas Andalas, Indonesia) | - |
| 2026-10-15 | 10:25~10:35 | (Abstract) Cumulative LDL-Cholesterol Exposure and Cardiovascular Outcomes in Lower Extremity Arterial Disease: A Single-Center Retrospective Study | Joongmin Kim(National Health Insurance Service Ilsan Hospital, Korea) | - |
| 2026-10-15 | 10:35~10:45 | (Abstract) Clinical profile and outcomes of venous thromboembolism in critically ill patients in Bicol Medical Center | Karla Louise Velasco(Bicol Medical Center, Philippines, Philippines) | - |
| 2026-10-15 | 10:45~11:20 | Break | - | - |
| 2026-10-15 | 11:20~11:30 | (Abstract) Clinical Outcomes of Sodium-Glucose Cotransporter-2 Inhibitors Use After Acute Myocardial Infarction in Patients with Type 2 Diabetes: A Nationwide Population-Based Cohort Study | Sang Young Kim(Yonsei Univ., Korea) | - |
| 2026-10-15 | 11:30~11:40 | (Abstract) On-Beta-Blocker Heart Rate and the Safety of Beta-Blocker Discontinuation in Stabilized Patients After Myocardial Infarction: A Secondary Analysis of the SMART-DECISION Trial | Ho Sung Jeon(Yonsei Wonju Univ., Korea) | - |
| 2026-10-15 | 11:40~11:50 | (Abstract) Differential Prognostic Impact of Nebivolol in STEMI Survivors After Primary PCI: A Risk-Calibrated Analysis | Seung-Woon Rha(Korea Univ., Korea) | - |
| 2026-10-15 | 11:50~12:00 | (Abstract) Bisoprolol versus Nebivolol after Percutaneous Coronary Intervention in Acute Myocardial Infarction with Reduced Left Ventricular Ejection Fraction | JunChang Jeong(Yeungnam Univ., Korea) | - |
| 2026-10-15 | 12:00~12:10 | (Abstract) Ultra-short (≤ 1 Month) versus Standard-Duration Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Undergoing PCI | Hendrianus Hendrianus(Natuna General Hospital, Indonesia) | - |
| 2026-10-15 | 12:10~12:20 | (Abstract) PREDICTORS OFOUTCOMES OF PATENT DUCTUS ARTERIOSUS (PDA)DEVICE CLOSURE WITH MODERATE TO SEVERE PULMONARY ARTERIAL HYPERTENSION (PAH)AMONG PEDIATRIC PATIENTS AT A TERTIARY CARDIAC CENTER | francis ed gahuman(Philippine Heart Center, Philippines) | - |
| 2026-10-15 | 12:20~13:45 | Lunch & Break | - | - |
| 2026-10-15 | 13:45~13:53 | (Case) Stent Implantation for Right Inferior Pulmonary Vein Stenosis which is caused by Angiosarcoma from Left Atrium. | Hoyoung Son(Chonnam National Univ., Korea) | - |
| 2026-10-15 | 13:53~14:01 | (Case) Systemic Thrombolytic Resistance in Antithrombin III Deficiency Rescued by Catheter-Directed Thrombolysis | Byengju Son(Dong Kang Hospital, Korea) | - |
| 2026-10-15 | 14:01~14:09 | (Case) Utility of Hybrid Ablation Techniques in Resistant Calcium and a Stuck Burr | Thomas George(Caritas Heart Institute, India) | - |
| 2026-10-15 | 14:09~14:17 | (Case) Systemic Thrombolysis for High-Risk Pulmonary Embolism in Advanced Hepatocellular Carcinoma: A Therapeutic Dilemma in a Resource-Limited Setting | Lutfi Hafiz Zunardi(Sunan Kalijaga General Hospital, Indonesia) | - |
| 2026-10-15 | 14:17~14:25 | (Case) Iatrogenic Right Coronary Artery Dissection and perforation During Staged PCI with a back ground of early ISR: A Potentially Catastrophic Complication Managed Successfully | Abdul Manan Bari(PGHI Hospital Islamabad, Pakistan) | - |
| 2026-10-15 | 14:25~14:33 | (Case) Post-PCI Recurrent Coronary Vasospasm Suggesting Overlap of Type I and Type II Kounis syndrome | Yesui Gankhuyag(Second State Central Hospital of Mongolia, Mongolia) | - |
| 2026-10-15 | 14:33~14:41 | (Case) The Calcium Score Paradox in Acute Coronary Syndrome: Intravascular Ultrasound-guided Percutaneous Coronary Intervention for Non-calcified Vulnerable Ostial Left Anterior Descending Artery Plaque Detected by Coronary Computed Tomography Angiography | Sonya Aprelladiva(Universitas Indonesia Hospital, Indonesia) | - |
| 2026-10-15 | 14:41~14:49 | (Case) Fulminant Cardiac Tamponade During Rituximab Therapy for Refractory Anti-N-Methyl-D-Aspartate Receptor Encephalitis Resulting in Obstructive Cardiac Arrest: A Case Report | Rachelle Anne Cruz(Asian Hospital And Medical Center, Philippines) | - |
| 2026-10-15 | 14:49~15:10 | Break | - | - |
| 2026-10-15 | 15:10~15:20 | (Abstract) Explainable AI-ECG for Occlusive Myocardial Infarction Detection and Revascularization Stratification: An International Multicenter Validation Study | Chiao Hsiang Chang(National Defense Medical University, Taipei, Taiwan, R.O.C., Taiwan) | - |
| 2026-10-15 | 15:20~15:30 | (Abstract) Prevalence and Prognostic Impact of Coronary Microvascular Dysfunction According to Heart Failure: Insights from the Multicenter FLOW-CMD Registry | Sang Yoon Lee(Sungkyunkwan Univ., Korea) | - |
| 2026-10-15 | 15:30~15:40 | (Abstract) AI-Driven Precision Medicine for DAPT Duration After PCI: A Patient-Level Pooled Analysis of Two Randomized Trials | Junpil Yun(Seoul Univ., Korea) | - |
| 2026-10-15 | 15:40~15:50 | (Abstract) Artificial intelligence enabled Electrocardiographic prediction and Global risk Index Stratification (AEGIS) score for Predicting Ejection Fraction Decline After Myocardial Infarction with preserved ejection fraction - A Single Center Retrospective Cohort Study | Ohchul Kwon(Seoul Univ., Korea) | - |
| 2026-10-15 | 15:50~16:00 | (Abstract) De-escalation Antiplatelet Strategies in High-Ischemic Risk Patients After Acute Coronary Syndrome: An Individual Patient Data Meta-analysis | Sang Hyun Kim(Armed Forces Capital Hospital, Korea) | - |
| 2026-10-15 | 16:00~16:10 | (Abstract) Prognostic Implication of CYP2C19 Genotype During Chronic Clopidogrel Monotherapy After Percutaneous Coronary Intervention | Jinhwan Jo(Chung-Ang Univ., Korea) | - |
| 2026-10-15 | 16:10~16:35 | - | - | - |
| 2026-10-15 | 16:35~16:45 | (Abstract) Fully Automated Multi-Chamber Strain Profiling in Consecutive All-Comer Echocardiography: Feasibility, Phenotyping, and Prognostic Implications | Su A Noh(Seoul Univ.,Seoul Univ., Korea) | - |
| 2026-10-15 | 16:45~16:55 | (Abstract) Physiological Left Atrial Staging in Hypertrophic Cardiomyopathy and the Risk of New-onset Atrial Fibrillation | Jaehyun Lim(Seoul Univ., Korea) | - |
| 2026-10-15 | 16:55~17:05 | (Abstract) Beyond Symptoms: Development and Internal Validation of a Prognostic Risk Score in Isolated Severe Tricuspid Regurgitation | Da-Eun Sung(Sungkyunkwan Univ., Korea) | - |
| 2026-10-15 | 17:05~17:15 | (Abstract) Lipoprotein(a) and Progression of Aortic Valve Stenosis :A Propensity Analysis | Ga Yun Kim(Ulsan Univ., Korea) | - |
| 2026-10-15 | 17:15~17:25 | (Abstract) Progressive Inflammatory Plaque Remodeling in Cardiac Allograft Vasculopathy: A Five-Year Serial Optical Coherence Tomography Study | Marina Arai(Tohoku University Graduate School of Medicine, Japan) | - |
| 2026-10-15 | 17:25~17:35 | (Abstract) Refined Annotations and Specialized Augmentation for Minor Epicardial Arteries in Coronary Angiography | Do-Hyun Kim(Seoul Univ., Korea) | - |
| 2026-10-15 | 08:30~08:40 | (Abstract) Exploratory Identification of Candidate Digital Biomarkers for Heart Failure Using Smartphone-Based Remote Photoplethysmography | Jooyeon Lee(Yonsei Univ., Korea) | - |
| 2026-10-15 | 08:40~08:50 | (Abstract) Long-Term Prognostic Value of Artificial Intelligence Estimated Left Ventricular Systolic Function From Electrocardiography : A Nationwide Cohort Study | DeaYoung Kim(Inha Univ., Korea) | - |
| 2026-10-15 | 08:50~09:00 | (Abstract) Effectiveness of a Family-Engaged AI Coaching Web Application for Improving Self-Management in Patients with Heart Failure | Seung Mi Moon(Hanyang Univ., Korea) | - |
| 2026-10-15 | 09:00~09:10 | (Abstract) Artificial intelligence-enabled electrocardiography for detecting elevated left ventricular filling pressure: development and multi-cohort validation from echocardiography to point-of-care | Minseong Kim(Yonsei University, Korea) | - |
| 2026-10-15 | 09:10~09:20 | (Abstract) Artificial intelligence-enabled Electrocardiography Reflects Serial Changes in Left Ventricular Ejection Fraction | Minjae Yoon(Seoul Univ., Korea) | - |
| 2026-10-15 | 09:20~09:30 | (Abstract) Artificial intelligence-derived electrocardiographic aging and heart failure subtype-specific risk | Seyong Chung(Yonsei Univ., Korea) | - |
| 2026-10-15 | 09:30~09:55 | Break | - | - |
| 2026-10-15 | 09:55~10:05 | (Abstract) Cardiorenal anemia syndrome and clinical outcomes in patients hospitalized for acute heart failure: A post-hoc analysis from the TRANS-HF trial | Moojun Kim(National Health Insurance Service Ilsan Hospital, Korea) | - |
| 2026-10-15 | 10:05~10:15 | (Abstract) Post-Discharge Blood Pressure Trajectories and Prognosis in Patients Hospitalized for Acute Heart Failure: Insights from the KorHF III Registry | Seon-Ah Jin(Chungnam National Univ., Korea) | - |
| 2026-10-15 | 10:15~10:25 | (Abstract) Kidney Dysfunction Drives the Prognostic Burden of Cardiovascular-Kidney-Metabolic Syndrome in Acute Heart Failure with Reduced Ejection Fraction | Jooyeon Lee(Yonsei Univ., Korea) | - |
| 2026-10-15 | 10:25~10:35 | (Abstract) Exercise Training / Heart Failure Medical Treatment | Anand Patil(Medicover Hospitals, Navi Mumbai, India) | - |
| 2026-10-15 | 10:35~10:45 | (Abstract) Prognostic value of the CONUT nutritional score in HFpEF: a large-scale cohort study evaluating inflammation-driven effect modification | Jiaying Yang(Fuwai Hospital, CAMS&PUMC , China) | - |
| 2026-10-15 | 10:45~10:55 | (Abstract) Prognostic value of NT-proBNP in the new era of heart failure with reduced EF treatment | Nguyen Vu Dat(Nguyen Tri Phuong Hospital, Vietnam) | - |
| 2026-10-15 | 10:55~11:05 | (Abstract) Beta Blockers Drive the Adherence-Outcome Association After Acute Heart Failure: A Component-Level Analysis from the TRANS-HF trial | Moojun Kim(National Health Insurance Service Ilsan Hospital, Korea) | - |
| 2026-10-15 | 11:05~11:20 | Break | - | - |
| 2026-10-15 | 11:20~11:30 | (Abstract) Association of glycemic control with coronary plaque phenotype and burden: a CCTA study in patients with T2DM | Xinyu Liu(West China School of Public health and West China Fourth Hospital, SiChuan University, China) | - |
| 2026-10-15 | 11:30~11:40 | (Abstract) A Deep Learning-Based CT Quantitative Risk Model for Delayed Endothelialization After Left Atrial Appendage Occlusion | Qingsong Wang(PLA General Hospital, China) | - |
| 2026-10-15 | 11:40~11:50 | (Abstract) Quantitative Non-Contrast Cardiac Magnetic Resonance for Assessment of Residual Leaks After Left Atrial Appendage Occlusion A Diagnostic Accuracy Study Compared with Cardiac CTA | Qingsong Wang(PLA General Hospital, China) | - |
| 2026-10-15 | 11:50~12:00 | (Abstract) CCTA Assessment of a Distinct Coronary Phenotype in Pneumoconiosis: Predominance of Noncalcified Plaque and Vascular Inflammation | Dan Lin(West China School of Public health and West China Fourth Hospital, SiChuan University, China) | - |
| 2026-10-15 | 12:00~12:10 | (Abstract) Myocardial Fibrosis as a Stronger Risk Factor for Arrhythmic Mitral Valve Prolapse: A Risk Stratification with Cardiac Magnetic Resonance | Elen Elen(National Cardiovascular Center Harapan Kita, Indonesia) | - |
| 2026-10-15 | 12:10~12:20 | (Abstract) A Small Segment, A Big Impact: The Hidden Risk of Left Main Coronary Calcification | Ruth Tri Mentari Lase(University of North Sumatera, Indonesia) | - |
| 2026-10-15 | 12:20~12:30 | (Abstract) Synergizing Anatomy and Function : Coronary Artery Calcium Score Meets AR-A Duration as Powerful Predictor of Major Adverse Cardiovascular Events | Shanda Yudistiawan(University of North Sumatera, Indonesia) | - |
| 2026-10-15 | 12:30~13:45 | Lunch & Break | - | - |
| 2026-10-15 | 13:45~13:53 | (Case) A Rare Reversible Etiology of Pediatric Dilated Cardiomyopathy | Donghee Jang(Ulsan Univ., Korea) | - |
| 2026-10-15 | 13:53~14:01 | (Case) Anatomical repair in a patient with congenitally corrected transposition of the great arteries, ventricular septal defect and tricuspid valve straddling | Youngkwan Song(Ulsan Univ., Korea) | - |
| 2026-10-15 | 14:01~14:09 | (Case) A Challenging Journey to the Systemic Ventricle with Dextrocardia: Catheter Ablation of Ventricular Tachycardia in a Patient with Functional Single Ventricle after Lateral Tunnel Fontan operation | Ji Eun Ban(Sejong Hospital, Korea) | - |
| 2026-10-15 | 14:09~14:17 | (Case) Peripheral Arterial Pseudoaneurysm in an Adolescent With Severe Rheumatic Heart Disease: A Rare Case Report | Maria Jeanlin Lagamayo(Philippine Heart Center, Philippines) | - |
| 2026-10-15 | 14:17~14:25 | (Case) Provisional Bifurcation Stenting Technique for Complex Stenosed Ductus Arteriosus and Pulmonary Artery Bifurcation: A Life-Saving Novel Strategy for Ductal Stenting in PA-IVS | Dela Ulfiarakhma(National Cardiovascular Center Harapan Kita Jakarta, Indonesia) | - |
| 2026-10-15 | 14:25~14:33 | (Case) Successful Aortic Valve Repair in an Infant with Complex Congenital Bicuspid Aortic Stenosis Initially Considered for Valve Replacement | Han Cho(Seoul Univ., Korea) | - |
| 2026-10-15 | 14:33~14:41 | (Case) Total physiological pacing in a patient with TGA post-atrial switch operation (Mustard) | Wasim Rashid(Severance cardiovascular hospital, Korea) | - |
| 2026-10-15 | 14:41~14:49 | (Case) First-in-human combined pulsed-fieldand radiofrequency ablation for ventricular tachycardia substrate modification in repaired tetralogy of Fallot with Melody valve | Wasim Rashid(Severance cardiovascular hospital, Korea) | - |
| 2026-10-15 | 14:49~14:57 | (Case) Trans catheter closure of Abernathy malformation in a young boy. | Avinash Anantharaj(JIPMER Puducherry India, India) | - |
| 2026-10-15 | 14:57~15:10 | Break | - | - |
| 2026-10-15 | 15:10~15:20 | (Abstract) Deviation from AI-learned electrocardiographic age and sex representations reveals physiological vulnerability to major adverse cardiovascular events | Hanjin Park(Yonsei Univ., Korea) | - |
| 2026-10-15 | 15:20~15:30 | (Abstract) Artificial Intelligence (AI)?Enhanced Electrocardiography (ECG) as a Screening Tool for Clinically Significant Mitral Stenosis (MS) and Mitral Regurgitation (MR) in a Rheumatic-Endemic Population | Muhamad Fajri Addai(National Cardiovascular Center Harapan Kita, Jakarta, Indonesia) | - |
| 2026-10-15 | 15:30~15:40 | (Abstract) Enhancing Cardiovascular Disease Prevention and Triage through an AI-Assisted Regional ECG Collaborative Network | Qingsong Wang(PLA General Hospital, China) | - |
| 2026-10-15 | 15:40~15:50 | (Abstract) Clinical efficacy of a digital therapeutic for cardiac rehabilitation : a multicenter randomized controlled trial | Jun Hyeong Song(Inje Univ., Korea) | - |
| 2026-10-15 | 15:50~16:00 | (Abstract) Cardiac Yoga Protocol Improves Exercise Capacity and Attenuates Vascular Inflammation in Patients with Coronary Artery Disease Following Percutaneous Coronary Intervention: A Randomized Controlled Trial | Swati Kumari(Post Graduate Institute Of Medical Education and Research, India) | - |
| 2026-10-15 | 16:00~16:10 | (Abstract) Low LDL-Cholesterol and the Risk of Hemorrhagic Stroke in Patients with Atrial Fibrillation Patients Initiating Anticoagulation: A Nationwide Cohort Study | Seokmoon Han(Seoul Univ., Korea) | - |
| 2026-10-15 | 16:10~16:20 | (Abstract) The Relationship Between Triglycerides Glucose Index with Coronary Artery Disease in Patients with Positive Treadmill Test | Oeij Henri Wijaya(National Cardiovascular Center Harapan Kita, Jakarta, Indonesia) | - |
| 2026-10-15 | 16:20~16:35 | Break | - | - |
| 2026-10-15 | 16:35~16:45 | (Abstract) Gene-Specific Clonal Hematopoiesis and Cardiovascular Disease as Independent Risk Factors for Incident Dementia: A UK Biobank Study | 김문현(이화의대) | - |
| 2026-10-15 | 16:45~16:55 | (Abstract) Clinical Predictors of Stroke in the Hemodialysis Population: Evidence from a National Health Insurance Cohort | 심가온(전북의대) | - |
| 2026-10-15 | 16:55~17:05 | (Abstract) Muscle-strengthening Activity and Clinical Outcomes after Incident Atrial Fibrillation: A Korean Nationwide Cohort Study | 정재욱(서울의대) | - |
| 2026-10-15 | 17:05~17:15 | (Abstract) Degree of Urbanization and the Prevalence of Hypertension and Diabetes Mellitus in South Korea (Insight from Gyeonggi Province): A Cross-Sectional Analysis with Temporal Trends, 2008?2023 | 최상석(가톨릭의대) | - |
| 2026-10-15 | 17:15~17:25 | (Abstract) Cardiovascular-kidney-metabolic syndrome among Korean young adults: KNHANES 2008-2024 | 김효진(서울의대) | - |
| 2026-10-15 | 17:25~17:35 | (Abstract) Esomeprazole Cotherapy and Bleeding Outcomes in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants | 노형준(중앙보훈병원) | - |
| 2026-10-15 | 17:35~17:45 | (Abstract) Performance Evaluation of a PCG-PPG-Based Multimodal AI Architecture for the Diagnosis of Valvular Heart Disease. | Qun Wei(계명의대) | - |
| 2026-10-15 | 08:30~08:45 | Congenital Coronary Anomalies: Diagnosis, Risk Stratification, and Contemporary Management | 윤자경(성균관의대) | - |
| 2026-10-15 | 08:45~09:00 | Coronary Complications in Repaired CHD: ASO, Ross, and Beyond | 김응래(부천세종병원) | - |
| 2026-10-15 | 09:00~09:15 | Nuclear Myocardial Perfusion Imaging in Pediatric and Congenital Heart Disease | 한상원(울산의대) | - |
| 2026-10-15 | 09:15~09:30 | Coronary Evaluation and Intervention in Kawasaki Disease Patients with Coronary Aneurysm/Stenosis: FFR, IVUS, and Beyond | 강지훈(서울의대) | - |
| 2026-10-15 | 09:30~09:45 | CABG in Kawasaki Disease: Indications, Conduit Selection, and Long-term Outcome | 윤영남(연세의대) | - |
| 2026-10-15 | 09:45~09:55 | Break | - | - |
| 2026-10-15 | 09:55~10:10 | Borderline Anatomy: One- or Two-Ventricle Repair? Decision-making and Long Term Outcome | 차슬기(울산의대) | - |
| 2026-10-15 | 10:10~10:25 | One-and-a-Half-Ventricle Repair: Indications, Techniques, and Long-term Outcomes | 양지혁(성균관의대) | - |
| 2026-10-15 | 10:25~10:40 | Pre-operative Imaging in Single Ventricle | 은영민(연세의대) | - |
| 2026-10-15 | 10:40~10:55 | Pre-Fontan Evaluation: When Is the Patient Ready? Hemodynamic Assessment, and Risk Stratification | 장소익(부천세종병원) | - |
| 2026-10-15 | 10:55~11:10 | Modern Fontan Completion: Conduit Selection, Fenestration Strategy, and Surgical Refinements | 곽재건(서울의대) | - |
| 2026-10-15 | 11:10~11:20 | Break | - | - |
| 2026-10-15 | 11:20~11:35 | Surgical Requirement after Fontan (Conduit Change, Valve Repair, Subaortic Stenosis Repair...) | 최은석(울산의대) | - |
| 2026-10-15 | 11:35~11:50 | Failing Fontan: Definition, Early Recognition and Risk Stratification | 이상윤(서울의대) | - |
| 2026-10-15 | 11:50~12:05 | Medical Therapy for the Failing Fontan: Pulmonary Vasodilators, SGLT2 Inhibitors, and the ISHLT 2025 Update | 김수진(부천세종병원) | - |
| 2026-10-15 | 12:05~12:20 | Mechanical Circulatory Support in Single Ventricle: VAD Strategy in Pre-Fontan and Failing Fontan | 신유림(연세의대) | - |
| 2026-10-15 | 12:20~12:35 | Heart and Combined Heart-Liver Transplantation in Fontan: Indications, Allocation and Outcomes | 송진영(성균관의대) | - |
| 2026-10-15 | 12:35~13:45 | Lunch & Break | - | - |
| 2026-10-15 | 13:45~14:00 | Frailty in Cardiovascular Care: Assessment and Prognostic Implications | 김광준(연세의대) | - |
| 2026-10-15 | 14:00~14:15 | Can We Prevent or Reverse Frailty? The Role of Exercise | 이규완(이화여자대학교) | - |
| 2026-10-15 | 14:15~14:30 | Can We Prevent or Reverse Frailty? The Role of Nutrition | 임현정(경희대학교) | - |
| 2026-10-15 | 14:30~14:45 | From Guidelines to Individualized Care: Cardiovascular Treatment Decisions in Frail Older Adults | 오규철(가톨릭의대) | - |
| 2026-10-15 | 14:45~15:00 | Discussion | - | - |
| 2026-10-15 | 15:00~15:10 | Break | - | - |
| 2026-10-15 | 15:10~15:25 | Echocardiographic Assessment in Adults with Repaired Tetralogy of Fallot | 이재영(가톨릭의대) | - |
| 2026-10-15 | 15:25~15:40 | The Role of Cardiac MRI and CT in Adults with Repaired Tetralogy of Fallot | 구현우(울산의대) | - |
| 2026-10-15 | 15:40~15:55 | Transcatheter Management in Adults with Repaired Tetralogy of Fallot | 김기범(서울의대) | - |
| 2026-10-15 | 15:55~16:10 | Arrhythmia Risk and Management in Adults with Repaired Tetralogy of Fallot | 엄재선(연세의대) | - |
| 2026-10-15 | 16:10~16:25 | Surgical Management in Adults with Repaired Tetralogy of Fallot | 이창하(부천세종병원) | - |
| 2026-10-15 | 16:25~16:35 | Break | - | - |
| 2026-10-15 | 16:35~16:50 | Diagnosis and Evaluation of Native, Residual, and Recurrent Coarctation in Adults | 변정희(부산의대) | - |
| 2026-10-15 | 16:50~17:05 | Catheter-Based Treatment for Coarctation of the Aorta in Adults | 장소익(세종병원) | - |
| 2026-10-15 | 17:05~17:20 | Surgical Treatment for Coarctation of the Aorta in Adults | 김형태(부산의대) | - |
| 2026-10-15 | 17:20~17:35 | Hypertension in Adults with Coarctation of the Aorta: Before and After Repair | 박재형(고려의대) | - |
| 2026-10-15 | 17:35~17:50 | Late Aortic Complications after Coarctation Repair | 김웅한(서울의대) | - |
비고
사전등록: 교수,개원의,봉직의-120000 / 전임의,전공의,기타-70000현장등록: 교수,개원의,봉직의-150000 / 전임의,전공의,기타-90000
문의처
담당자
조윤하
연락처
02-3275-5258
이메일
herz8@circulation.or.kr